References Sikiric P, et al
This novel GLP-1 receptor agonist, beyond its roots as a diabetes drug, has shown significant efficacy in promoting weight loss and improving metabolic health in adults with obesity, excluding those with diabetes
In particular, CJC-1295 has been demonstrated to preserve growth hormones physiologic effects on hyperplasia, hypertrophy, bone density, blood sugar, fat metabolism, protein synthesis, and myocardial (heart cell) function
He said that for the average employer that covers these products for weight loss, GLP-1s now equate to about 3% of their total healthcare costs
From TikTokers calling Berberine natures Ozempic to the type 2 diabetes-turned-weight-loss drug making headlines for an array of interesting side effects (Ozempic face to Ozempic butt to name a few), now people are wondering: does Ozempic make you tired